UREAPHIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ureaphil, and what generic alternatives are available?
Ureaphil is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in UREAPHIL is urea. There is one drug master file entry for this compound. Additional details are available on the urea profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for UREAPHIL?
- What are the global sales for UREAPHIL?
- What is Average Wholesale Price for UREAPHIL?
Summary for UREAPHIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 216 |
| Patent Applications: | 3,372 |
| DailyMed Link: | UREAPHIL at DailyMed |
US Patents and Regulatory Information for UREAPHIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | UREAPHIL | urea | INJECTABLE;INJECTION | 012154-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
